Nisa Investment Advisors’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52K Hold
811
﹤0.01% 2724
2026
Q1
$2.18K Hold
811
﹤0.01% 2604
2025
Q4
$1.78K Hold
811
﹤0.01% 2625
2025
Q3
$1.9K Sell
811
-101
-11% -$173 ﹤0.01% 2635
2025
Q2
$1.39K Buy
912
+718
+370% +$1.12K ﹤0.01% 2680
2025
Q1
$269 Sell
194
-737
-79% -$1.57K ﹤0.01% 2887
2024
Q4
$2.11K Buy
931
+120
+15% +$421 ﹤0.01% 2473
2024
Q3
$3.83K Sell
811
-751
-48% -$4.34K ﹤0.01% 2271
2024
Q2
$11.7K Buy
1,562
+1,524
+4,011% +$18.7K ﹤0.01% 2100
2024
Q1
$648 Buy
38
+15
+65% +$322 ﹤0.01% 2454
2023
Q4
$522 Hold
23
﹤0.01% 2397
2023
Q3
$350 Buy
+23
New +$314 ﹤0.01% 2591

Other funds holding CABA

Nisa Investment Advisors's CABA Position: Q2 2026 in Review

Nisa Investment Advisors held its Cabaletta Bio (CABA) position steady in Q2 2026 at 811 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Nisa Investment Advisors first reported a position in CABA in Q3 2023 and has held it in 12 quarters since. The position peaked at $11.7K in Q2 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Nisa Investment Advisors held 811 shares of Cabaletta Bio worth $2.52K as of Q2 2026.
  • Nisa Investment Advisors left its Cabaletta Bio share count unchanged in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2724 holding.
  • Nisa Investment Advisors first reported a position in Cabaletta Bio in Q3 2023 and has held it in 12 quarters since.
  • Nisa Investment Advisors's Cabaletta Bio position peaked at $11.7K in Q2 2024.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.